Cargando…

Semaphorin 6D as an independent predictor for better prognosis in clear cell renal cell carcinoma

INTRODUCTION: Clear cell renal cell carcinoma (ccRCC) is the most common type of RCC and is associated with poor survival. However, the mechanisms underlying its development have not been thoroughly investigated. Semaphorin 6D (SEMA6D) is differentially expressed in various cancers, including lung a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Jiachen, Jin, Mengyuan, Qiao, Baoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124703/ https://www.ncbi.nlm.nih.gov/pubmed/35605459 http://dx.doi.org/10.1016/j.tranon.2022.101453

Ejemplares similares

LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p
por: Ye, Zhuo, et al.
Publicado: (2019)

Ubiquitin-specific peptidase 2 inhibits epithelial-mesenchymal transition in clear cell renal cell carcinoma metastasis by downregulating the NF-κB pathway
por: Duan, Jiachen, et al.
Publicado: (2022)

Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma
por: Wang, Hongkai, et al.
Publicado: (2016)

Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma
por: Choi, Y, et al.
Publicado: (2013)

High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma
por: Pan, Deng, et al.
Publicado: (2015)

Prognostic and Diagnostic Values of Semaphorin 5B and Its Correlation With Tumor-Infiltrating Immune Cells in Kidney Renal Clear-Cell Carcinoma
por: Ding, Junping, et al.
Publicado: (2022)

Delta-like ligand 4: A predictor of poor prognosis in clear cell renal cell carcinoma
por: WANG, WEI, et al.
Publicado: (2014)

Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma
por: Saroufim, A, et al.
Publicado: (2014)

Upregulation of MYBL2 independently predicts a poorer prognosis in patients with clear cell renal cell carcinoma
por: Sun, Shan-Shan, et al.
Publicado: (2020)

Construction of an interferon regulatory factors-related risk model for predicting prognosis, immune microenvironment and immunotherapy in clear cell renal cell carcinoma
por: Pan, Hao, et al.
Publicado: (2023)

Preoperative Butyrylcholinesterase Level as an Independent Predictor of Overall Survival in Clear Cell Renal Cell Carcinoma Patients Treated with Nephrectomy
por: Koie, Takuya, et al.
Publicado: (2014)

Long Noncoding RNA HOTTIP Serves as an Independent Predictive Biomarker for the Prognosis of Patients with Clear Cell Renal Cell Carcinoma
por: Liu, Zhanxin, et al.
Publicado: (2020)

Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma
por: Su, Hengchuan, et al.
Publicado: (2016)

Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma
por: Yao, Yicong, et al.
Publicado: (2021)

Application of m(6)A and TME in Predicting the Prognosis and Treatment of Clear Cell Renal Cell Carcinoma
por: Pei, Dongchen, et al.
Publicado: (2022)

Preoperative low-density lipoprotein cholesterol as a predictor of favorable prognosis in patients with clear cell renal cell carcinoma
por: Mei, Yangyang, et al.
Publicado: (2023)

Semaphorin-3D and Semaphorin-3E Inhibit the Development of Tumors from Glioblastoma Cells Implanted in the Cortex of the Brain
por: Sabag, Adi D., et al.
Publicado: (2012)

miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma
por: Ran, LongJiao, et al.
Publicado: (2017)

Predicting prognosis and immunotherapeutic response of clear cell renal cell carcinoma
por: Wang, Jun, et al.
Publicado: (2022)

Better prediction of clinical outcome in clear cell renal cell carcinoma based on a 6 metabolism-related gene signature
por: Yu, Zhixian, et al.
Publicado: (2023)

Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients
por: Wan, Fangning, et al.
Publicado: (2015)

Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma
por: Yao, Yicong, et al.
Publicado: (2021)

Commentary: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma
por: Temiz, Mustafa Zafer
Publicado: (2021)

Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma
por: Yang, Liu, et al.
Publicado: (2015)

DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma
por: Bao, Yewei, et al.
Publicado: (2021)

Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma
por: Gao, Lei, et al.
Publicado: (2020)

The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma
por: Mou, Yanhua, et al.
Publicado: (2020)

FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis
por: Zhang, Yixiao, et al.
Publicado: (2020)

The semaphorins
por: Yazdani, Umar, et al.
Publicado: (2006)

Semaphorin 6D–expressing mesenchymal cells regulate IL-10 production by ILC2s in the lung
por: Naito, Maiko, et al.
Publicado: (2022)

Low level of Cyclin‐D1 correlates with worse prognosis of clear cell renal cell carcinoma patients
por: Wang, Qing‐shui, et al.
Publicado: (2019)

Identification and Quantification of Necroptosis Landscape on Therapy and Prognosis in Kidney Renal Clear Cell Carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

Comprehensive assessment gene signatures for clear cell renal cell carcinoma prognosis
por: Chang, Peng, et al.
Publicado: (2018)

Expression of AOX1 Predicts Prognosis of Clear Cell Renal Cell Carcinoma
por: Xiong, Luyang, et al.
Publicado: (2021)

Key genes associated with prognosis and metastasis of clear cell renal cell carcinoma
por: Zhong, Tingting, et al.
Publicado: (2022)

ASNS can predict the poor prognosis of clear cell renal cell carcinoma
por: Gan, Xinqiang, et al.
Publicado: (2022)

EMILIN2 is associated with prognosis and immunotherapy in clear cell renal cell carcinoma
por: Zhao, Guangjian, et al.
Publicado: (2022)

Mutational Spectrum of Semaphorin 3A and Semaphorin 3D Genes in Spanish Hirschsprung patients
por: Luzón-Toro, Berta, et al.
Publicado: (2013)

Abnormal expression of CEBPB promotes the progression of renal cell carcinoma through regulating the generation of IL-6
por: Ren, Yaoqiang, et al.
Publicado: (2023)

High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma
por: Zhu, Zhen-Peng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ca1al169utr091ue21jdg0sa7c